Tilray | TRLY - 营业费用

金融业

USD 4.12

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 3.03B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	营业费用	更改		日
Acasti Pharma	USD 48.21M		16.68M	2026-06
Akebia Therapeutics	USD 63.08M		8.26M	2025-12
Alaunos Therapeutics	USD 952K		60K	2026-06
Aurora Cannabis	CAD 76.28M		28.24M	2026-06
Avita Medical	AUD 28.56M		534K	2026-06
Canopy Growth	CAD 98.74M		23K	2026-06
Cronos Group	USD -33.51M		78.92M	2026-09
Dianthus Therapeutics	USD 62.24M		15.25M	2026-06
Divis Laboratories Ltd	INR 19.51B		660M	2026-06
Ionis Pharmaceuticals	USD 370.24M		6.24M	2026-06
IQVIA Holdings	USD 3.82B		2.05B	2026-09
Knight Therapeutics	CAD 126.9M		8.29M	2025-12
Moderna	USD 1.18B		223M	2026-09
Organigram Holdings	CAD 100.45M		30.86M	2026-06
Organon & Co	USD 1.19B		187M	2026-09
Revvity	USD 604.27M		719K	2026-09
Tectonic Therapeutic	USD 24.22M		3.08M	2026-06
Tilray	USD 237.52M		17.34M	2025-09
Viatris	USD 3.49B		189.1M	2026-09
Xeris Pharmaceuticals	USD 86.93M		11.72M	2026-06
Zealand Pharma A/S	573M		202.97M	2026-03